General Information
Drug ID
DR00103
Drug Name
Ethinyl estradiol
Synonyms
17 alpha-Ethinylestradiol; 17 alpha-Ethynylestradiol; 17 alpha-Ethynyloestradiol; 17 alpha-ethinyestradiol; 17-Ethinyl-3,17-estradiol; 17-Ethinyl-3,17-oestradiol; 17-Ethinylestradiol; 17-Ethynylestradiol; 17-Ethynyloestradiol; 17-alpha-Ethinyl-17-beta-estradiol; 17-alpha-Ethynyl-17-beta-oestradiol; 17-alpha-Ethynylestradiol; 17-alpha-Ethynylestradiol-17-beta; 17-alpha-Ethynylestradiol-l7-beta; 17-alpha-Ethynyloestradiol-17-beta; 17-alpha-ethynyl estradiol; 17.alpha.-Ethinyl-17.beta.-estradiol; 17.alpha.-Ethinylestradiol; 17.alpha.-Ethynyl-17.beta.-oestradiol; 17.alpha.-Ethynylestradiol; 17.alpha.-Ethynyloestradiol; 17a-Ethynylestradiol; 17alpha-Ethinyl estradiol; 17alpha-Ethinylestradiol; 17alpha-Ethinylestradiol-17beta; 17alpha-Ethynylestradiol; 17alpha-Ethynyloestradiol; 17alpha-Ethynyloestradiol-17beta; Aethinyloestradiolum; Aethinyoestradiol; Aethinyoestradiol [German]; Amenoron; Amenorone; Anovlar; Certostat; Chee-O-Gen; Chee-O-Genf; Component of Demulen; Component of Oracon; Component of Ortrel; Cyclosa; Dicromil; Diognat-E; Diogyn E; Diogyn-E; Diprol; Dyloform; EE(sub 2); EE2; ETHINYLESTRADIOL; Effik Brand of Ethinyl Estradiol; Ertonyl; Esteed; Estigyn; Estinyl; Estinyl (TN); Eston-E; Estopherol; Estoral; Estoral (Orion); Estoral (VAN);Estradiol, Ethinyl; Estoral [Orion]; Estorals; Estradiol, Ethynyl; Ethidol; Ethinoral; Ethinyl E2; Ethinyl Estradiol Hemihydrate; Ethinyl Estradiol [USP]; Ethinyl Estradiol, (8 alpha)-Isomer; Ethinyl Oestradiol Effik; Ethinyl estradiol (USP); Ethinyl-Oestradiol Effik; Ethinyl-oestranol; Ethinylestradiol (JP15/INN); Ethinylestradiol Jenapharm; Ethinylestradiol [INN:BAN:JAN]; Ethinylestradiolum; Ethinylestradiolum [INN-Latin]; Ethinylestriol; Ethinyloestradiol; Ethinyloestradiol [Steroidal oestrogens]; Ethy 11; Ethynyl estradiol; Ethynylestradiol; Ethynylestradiol, Ethinyl Estradiol; Ethynyloestradiol; Eticyclin; Eticyclol; Eticylol; Etinestrol; Etinestryl; Etinilestradiol; Etinilestradiol [INN-Spanish]; Etinilestradiolo; Etinilestradiolo [DCIT]; Etinoestryl; Etistradiol; Etivex; Feminone; Follicoral; Ginestrene; Hemihydrate, Ethinyl Estradiol; Inestra; Jenapharm Brand of Ethinyl Estradiol; Jenapharm, Ethinylestradiol; Kolpolyn; Linoral; Lynoral;Menolyn; Microfollin; Microfollin Forte; Neo-Estrone; Nogest-S; Novestrol; OVULEN-21; OVULEN-28; Oradiol; Orestralyn; Orestrayln; Organon Brand of Ethinyl Estradiol; Ortho-Cyclen; PUBERTAL ETHINYL ESTRADIOL STUDY; Palonyl; Perovex; Primogyn; Primogyn C; Primogyn M; Progynon C; Progynon M; Prosexol; Schering Brand of Ethinyl Estradiol; Spanestrin; Ylestrol
Drug Type
Small molecular drug
Indication Female hypogonadism [ICD11: 5A61.0] Approved [1]
Therapeutic Class
Estrogens
Structure
3D MOL 2D MOL
Formula
C20H24O2
Canonical SMILES
CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O
InChI
InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1
InChIKey
BFPYWIDHMRZLRN-SLHNCBLASA-N
CAS Number
CAS 57-63-6
Pharmaceutical Properties Molecular Weight 296.4 Topological Polar Surface Area 40.5
Heavy Atom Count 22 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 2
XLogP
3.7
PubChem CID
5991
PubChem SID
11404629 , 11533305 , 14898199 , 14922735 , 17389896 , 24702258 , 24714981 , 24869989 , 24894585 , 26512288 , 26719638 , 26753042 , 29215113 , 29225006 , 46386858 , 46508618 , 48413731 , 48415973 , 48421874 , 48423390 , 48425117 , 49854450 , 53788253 , 56311124 , 56311183 , 56311332 , 56311399 , 56311403 , 56311406 , 56311535 , 56312680 , 56313453 , 56313621 , 56313838 , 56313881 , 56314241 , 57288591 , 57650750 , 71821446 , 76025 , 78032044 , 7847620 , 7979198 , 81093168 , 8139942 , 8153725 , 92308409 , 92713395 , 93165614 , 9737
ChEBI ID
ChEBI:4903
TTD Drug ID
D06NXY
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Ethinyl estradiol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm Res. 2004 Jul;21(7):1284-93.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.